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Irismar Reis de OliveiraHow did you first become interested in
psychotherapy?
My decision to become a psychiatrist and psychoanalyst
dates back to the early 1970s, a few years before I
entered medical school at the age of 21. At that time, I
had read all the books written by psychoanalysts Karen
Horney and Erich Fromm. However, my interest in psy-
chological literature had started during adolescence,
when I was lucky enough to be introduced to Arthur
Harry Chapman, an American psychiatrist who used to
write psychotherapy books, and who decided to migrate
to my hometown, Vitória da Conquista, in Brazil. Thus,
just out of adolescence, I had the privilege of discussing
with a renowned American scholar about my intention
of enrolling in medical school and becoming a psych-
iatrist and psychotherapist. His work (e.g., [1,2]) relied
clearly on the ideas of Harry Stack Sullivan, the founder
of the interpersonal movement in psychotherapy. Also
importantly, I was exposed to autogenic training–a re-
laxation technique developed by the German psychiatrist
Johannes Schultz–as a client in the late 1960s, when I
was still a teenager.
However, during my medical course, I lost interest in
psychiatry and, at its conclusion, I applied for a resi-
dency in cardiology, after which I had a 2-year clinical
practice working in this specialty. At that time, I also
joined the Department of Pharmacology at the Federal
University of Bahia, in Salvador, Brazil, as an assistant
professor. Unfortunately (today I would say fortunately),
cardiology did not fulfill my professional and personal
expectations, and the original idea of becoming a psy-
choanalyst came to mind again. So, I registered at a
psychoanalysis-training institute and started personal
analysis, having read most of Freud’s books at that time.
My psychoanalysis training would continue in 1983, in
Paris, where I completed a 4-year residency in psych-
iatry. Initially and simultaneously with my psychiatricCorrespondence: irismar.oliveira@uol.com.br
Departamento de Neurociências e Saúde Mental, Universidade Federal da
Bahia, Salvador, Brazil
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reproduction in any medium, provided the ortraining at Sainte-Anne Hospital in Paris, I resumed per-
sonal analysis and followed a psychoanalysis university
course during which I was trained in Lacanian psycho-
analysis for 2 years. So, both personal analysis and psy-
choanalysis training in Brazil and in France summed up
5 years, after which, still living in Paris, I decided to
focus on clinical psychiatry and psychopharmacology.
In 1987, I received certification as a specialist in psy-
chiatry from the Faculté de Médicine Cochin Port Royal,
University of Paris V.
Returning to Brazil in 1988, I resumed teaching and
started research activities at the Department of Pharma-
cology, at Federal University of Bahia, where I would
remain until 1996. In 1995, I had received a Ph.D. in
neuropsychopharmacology, and in 1996 I joined the
Department of Neurosciences and Mental Health at the
same university, as an associate professor. In 1998, I redis-
covered psychotherapy and registered for the first extra-
mural cognitive therapy course by the Beck Institute for
Cognitive Therapy and Research (now the Beck Institute
for Cognitive Behavior Therapy) being held in Brazil.
The year 2000 was a turning point in my professional
life because I: (1) received a certification in cognitive
therapy from the Beck Institute, in Philadelphia; (2)
joined the Academy of Cognitive Therapy (http://www.
academyofct.org) as a founding fellow; (3) became full
professor of psychiatry at the Department of Neuros-
ciences and Mental Health, Federal University of Bahia;
and (4) became head of the psychiatry service at the uni-
versity hospital. I was gradually shifting clinical practice,
teaching, and research interests from an exclusive bio-
logical and psychopharmacological focus to an integrative
focus linking psychopharmacology and psychotherapy [3].
A multicenter randomized clinical trial (RCT) of topira-
mate and cognitive-behavior therapy (CBT) in the treat-
ment of binge-eating disorder was the first result of this
shift [4]. I did not realize at the time that I was also going
in the direction of the already existing psychotherapy inte-
gration movement.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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psychotherapy in particular?
In about a century and a half, since Freud developed
psychoanalysis, there has been an explosion of different
modalities of psychotherapies, enumerated as 551 by
Kazdin [5], and this number is expanding. Despite this
large number, and perhaps as a reaction to the long-
lasting hegemony of psychoanalysis, there was a decline
in the attention given to psychotherapy, at least by psy-
chiatrists, and a great increase of psychopharmacology
dominance was observed, stimulated by the discoveries
in biological psychiatry and psychopharmacology, as
well as the influence of the pharmaceutical industry.
Unfortunately, however, although safer than the older
drugs, the new drugs put onto the market since the
1990s did not completely fulfill the initial promises, and
psychiatric drug treatment remained an unmet need.
Furthermore, there seems to be a plateau or even a de-
crease in the development of new drugs in the last few
years, and this might be a possible explanation for the
rediscovery of the power of psychotherapy [6]. This re-
discovery has also been supported by the growing num-
ber of well-designed studies not only showing that
psychotherapy works, but that it works as well as, and
sometimes to a greater degree and longer, than drugs in
certain clinically relevant psychiatric conditions, like
depression, anxiety, marital dissatisfaction, substance
abuse, health problems and sexual dysfunction, as
demonstrated by numerous RCTs [7]. It also seems to
be more enduring both in clinical trials and in real
world studies [8].What does the future hold for psychotherapy
research and what do you think are its
limitations?
Referring to the future of psychotherapy research calls
for some reflections on its past and present. Historically,
psychoanalysis was the “first force,” and was followed by
behaviorism (second force) as a reaction to the “unscienti-
fic” nature of psychoanalysis theory and lack of connection
to observable phenomena. Some prominent behaviorists,
however, would later expand their models to incorporate
cognitions, as proposed by Albert Ellis, Aaron Beck and
others, and which emphasized the importance of mental
representation of the stimuli as central elements to psy-
chopathology. The third force emerged after World War
II and was referred to as the humanistic and experiential
approaches because these theoretical approaches were
based on the humanistic philosophers. Humanistic and
experiential treatments were mainly represented by
person-centered therapy developed by Carl Rogers, and
Gestalt therapy developed by Frederick Perls. There have
also been the fourth (feminist and multicultural theories)and the fifth (post-modern and constructivist theories)
forces [8].
Importantly, the approaches encompassed by each
force continued to evolve, resulting in multiple spinoffs.
Thus, it is not surprising that the huge number of
approaches originated from the above-mentioned forces
in psychotherapy called for the need for assessing the ef-
ficacy of such treatments, and gave rise to the “empiric-
ally validated treatments” project [9], which reduced the
number of validated psychotherapies to the fewer than
50 which demonstrated superiority over some type of
placebo by at least two RCTs. The word “validated” was
later replaced with “supported,” becoming “empirically
supported treatments” (EST).
Another movement derived from medicine, namely
evidence-based practice (EBP), was adopted by psycholo-
gists (APA Presidential Task Force on Evidence-Based
Practice, [10]) who defined EBP as “the integration of the
best available research with clinical expertise in the con-
text of patient characteristics, culture, and prefer-
ences,” and endorsed the multiple types of evidence that
contribute to effective practice in psychology, such as ef-
ficacy, effectiveness, cost-effectiveness, cost-benefit, epi-
demiology and treatment utilization [8].
Another consequence of the huge number of single-
school psychotherapy approaches was a movement that
started in the 1970s and gave rise to what came to be
known as the psychotherapy integration movement,
which encompassed common factors (an aspect of psy-
chotherapy that is present in most, if not all, approaches
to treatment), theoretical integration (synthesis of two or
more theories into a single conceptualization), technical
integration (use of techniques drawn from several diffe-
rent therapeutic approaches), and assimilative integra-
tion (one theoretical position is accompanied by a
willingness to incorporate techniques from other thera-
peutic approaches) [11,12].
Thus, my understanding is that what the future holds
for psychotherapy research is the challenge of answering
or clarifying many questions still incompletely explored,
some of which are: How does psychotherapy work? Are
some psychotherapies more effective than others? What is
the role of theory in psychotherapy? Is psychotherapy inte-
gration a solution for the complexities of the field? Some
of these questions are approached in the books of the The-
ories of Psychotherapy Series, organized by Carlson and
Englar-Carlson [12]. For those interested in knowing
more, I suggest you read The basics of psychotherapy: An
introduction to theory and practice [8], followed by Psy-
chotherapy integration [11], before going to each individ-
ual psychotherapy theory.
Limitations to psychotherapy integration, in my opinion,
may be more in excessive reliance of psychotherapists on
their theoretical allegiances and their unwillingness to talk
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What challenges and developments can we
expect to see in the next few years in
psychotherapy, and how can research contribute
to meeting these challenges?
I will approach this topic citing my own research, Trial-
Based Therapy (TBT) [6], as an example of assimilative
psychotherapy integration [13]. In this kind of integration,
various techniques from different theoretical origins are
incorporated within the context of understanding pro-
vided by the home theoretical approach [11]. TBT relies
on CBT as the organizing theory and adds technical inter-
ventions drawn from several other approaches. Among
them are gestalt, experiential, acceptance and commit-
ment therapy, compassion-focused therapy, metacognitive
therapy, mindfulness, and Mitchell’s [14] two-person rela-
tional model. Furthermore, by adding literature, TBT re-
lies on the work of Franz Kafka, The Trial, and some of its
techniques incorporate a law metaphor, by which the pa-
tient expresses multiple internal characters (e.g., prosecu-
tor, defense attorney, witnesses, jurors, etc.) to challenge
his/her core beliefs conceptualized as self-accusations [15].
As TBT is a 3-level, 3-phase, structured step-by-step ap-
proach, and its conceptualization involves a cyclic inter-
actional mechanism in which each component in each
level influences the other, this approach is flexible enough
to allow the therapist to adapt the treatment to the indivi-
dual’s needs and characteristics.
What topics are currently trending within the
field of psychotherapy?
Stahl’s [16] conceptualization of psychotherapies as epigen-
etic “drugs” is very attractive. It further strengthens the idea
that psychotherapy and drugs have a common underlying
mechanism of change. According to Stahl, learning and en-
vironmental experiences, such as psychotherapy, change
brain circuits, as do drugs. Thus, both psychotherapy and
psychopharmacology can be clinically effective for treating
psychiatric disorders, and their combination can be thera-
peutically synergistic. Psychotherapy and many other forms
of learning might induce epigenetic changes in brain cir-
cuits that would enhance the efficiency of information pro-
cessing in malfunctioning neurons to improve symptoms
in psychiatric disorders, just like drugs. Epigenetics might
be a trend in psychotherapy research.
Another trend in psychotherapy research is further
evaluating the efficacy, as well as consolidating the new
generation of psychotherapy approaches, both in the psy-
chodynamic and CBT umbrellas, relative to the more
traditional approaches. Examples of new psychodynamic
approaches are short-term anxiety-regulating psychother-
apy [17], brief relational therapy [18] and time-limiteddynamic psychotherapy [19], and examples of CBT
approaches are acceptance and commitment therapy
[20], dialectical behavioral therapy [21], metacognitive
therapy [22], mindfulness-based cognitive therapy [23]
and compassion-focused therapy [24].
Are there any particular papers you would like to
see submitted to your section?
Papers addressing psychotherapy integration, psychotherapy-
psychopharmacology integration, and mechanisms of
change in psychotherapy might be interesting ones.
What advantage do you think BMC Psychology
has over other journals?
First and foremost, BMC is a highly regarded editorial
group, publishes multiple journals in many different areas,
and as such, will make BMC Psychology one of the most
important sources of high quality research in a broad
range of disciplines in psychology. This and being an open
access journal make it a very advantageous source of pub-
lication in psychology.
Do you think psychotherapy would benefit from
an open access journal, such as BMC Psychology?
Open access to knowledge is a trend in science with
which I agree and adhere to, as demonstrated by my
open access cognitive therapy book recently published
[25]. As far as I know, there are few open access psych-
ology journals relative to other fields.
As you know BMC Psychology will operate an
open peer review process. How important do you
think this is to the field?
Peer review is the only way to assure quality and credibil-
ity of publications. However, Mahoney [26] called atten-
tion to confirmatory bias, defined as the tendency to
emphasize and believe experiences that support one’s
views and to ignore or discount those which do not. After
interviewing 75 reviewers to referee manuscripts which
described identical experimental procedures, but which
reported positive, negative, mixed, or no results, it was
concluded that reviewers were strongly biased against
manuscripts reporting results contrary to their theoretical
perspective. BMC Psychology is committed to an open
and integrative work, as demonstrated by the distinct
orientations of the section and associated editors list.
What made you interested in joining BMC
Psychology?
Although I am a psychiatrist, and have been publishing
mainly in psychopharmacology and biological psychiatry,
I also have been teaching psychotherapy for at least
10 years. More than 90% of my psychotherapy workshops
attendants in Brazil and in Europe are psychologists
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dominantly psychiatrists). Joining BMC Psychology as a
psychotherapy section editor presented to me as a great
opportunity to expand communication with scholars in
the field of psychotherapy all over the world.
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